Oral Anti Estrogen Tamoxifen Citrate / Nolvadex Cancer Treatment Steroids CAS 10540-29-1

 
Quick Detail:
 

Product name	Tamoxifen citrate Factory Supplying
Other name	Nolvadex
CAS register number	10540-29-1
EINECS	259-415-2
Molecular formula	C32H37NO8
Molecular weight	563.64
Molecular structure
Melting point	140-144 °C
Assay	99%
Appearance	White crystalline powder.
Package	1kg/aluminium foil bag or as required
Minimum order quantity	10g
Shipping	By express courier
Shipping leading time	Within 24 hours after receiving the payment
Payment options	Western Union, Moneygram, Bank transfer, paypal
Price	Negotiable

 

 
Description:
Nolvadex (tamoxifen citrate) is very comparable to Clomid, behaves in the same manner in all tissues, and is a mixed estrogen agonist/antagonist of the same type as Clomid. The two molecules are also very similar in structure. It is not correct that Nolvadex reduces levels of estrogen: rather, it blocks estrogen from estrogen receptors and, in those tissues where it is an antagonist, causes the receptor to do nothing.
The belief that it reduces gains seems to stem from the fact that the scientific literature reports a slight reduction in IGF-1 (individuals using anabolic steroids were not studied though) from use of Nolvadex.
Thus, Dan Duchaine reported that it reduces IGF-1 and therefore reduces gains. However, if this effect exists at all, it must be very minor, due to the excellent gains that many have made, and from the fact that no one has noticed any such thing from Clomid, which has the same activity profile.
The fact that Nolvadex will reduce water retention may result in the user agreeing that gains are less, since weight gain is less, thus reinforcing the bias.
 
Applications:
For the treatment of advanced, recurrent breast cancer and ovarian cancer and other illnesses. Used as an antineoplastic raw materials.
Biological Activity: Estrogen receptor antagonist/partial agonist. Selective and potent inhibitor of mammalian sterol isomerase. Neuroprotective in female rats in vivo . Also high affinity agonist at the membrane estrogen receptor GPR30.